| ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - MarketWatch (press release) |
|
|
MarketWatch (press release) 10, 2011 /PRNewswire via COMTEX/ -- ChemoCentryx, Inc. today announced positive preclinical results for its novel CCR2 antagonist at the 44th Annual Meeting of the American Society of Nephrology. CCR2 inhibition in diabetic mice resulted in rapid and |